The entire newsletter in a quick, easy to read format!
The FDA has approved many MS treatments to modify the disease, address relapses and manage symptoms. However, these treatments aren’t fully effective. Some people choose alternative medicine to improve their quality of life, usually in combination with their prescribed MS treatments. Researchers are looking into the benefits and risks of these therapies for MS and its symptoms. This month, we bring you three new studies with promising results! Read more…
The iConquerMS community contributes to impactful MS research. If you haven’t already, please consider joining today!
The ACP team is now 10 members strong! The CAFE-MS clinical trial is scheduled to start in spring 2024, and we’ve added two new staff members to lead this effort. Last month we introduced you to Jennifer Hill. This month, we extend a warm welcome to Grace Okafor, the Clinical Trial Manager for the study. Read more…
